Avery W. Catlin - 18 May 2022 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Avery Catlin
Issuer symbol
CRBP
Transactions as of
18 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 14:23:02 UTC
Previous filing
18 May 2022
Next filing
14 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option(right to buy) Award $0 +79,600 $0.000000 79,600 18 May 2022 Common Stock 79,600 $0.3300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.